Financial PerformanceAtriCure posted a solid Q1, with revenue relatively in line with estimates and the company continuing to show better than expected adjusted EBITDA.
GuidanceAtricure, Inc. raised its adjusted EBITDA and EPS guidance.
Market ExpansionOpportunities within its existing markets and significant expansion of its total addressable markets, growing to $10 billion from $5 billion.